Sayıner, Abdullah

Profile Picture
Profile URL
https://hdl.handle.net/20.500.14365/7689
Name Variants
Sayiner, Abdullah
Sayiner, A.
Job Title
Email Address
abdullah.sayiner@ieu.edu.tr
Main Affiliation
09.02. Internal Sciences
Status
Current Staff
Website
ORCID ID
0000-0002-6788-9727
Scopus Author ID
6701356820
Turkish CoHE Profile ID
0F3B97546E0817BF
Google Scholar ID
myeGv2oAAAAJ
WoS Researcher ID
LFQ-4173-2024

Sustainable Development Goals

NO POVERTY1
NO POVERTY
0
Research Products
ZERO HUNGER2
ZERO HUNGER
0
Research Products
GOOD HEALTH AND WELL-BEING3
GOOD HEALTH AND WELL-BEING
4
Research Products
QUALITY EDUCATION4
QUALITY EDUCATION
0
Research Products
GENDER EQUALITY5
GENDER EQUALITY
0
Research Products
CLEAN WATER AND SANITATION6
CLEAN WATER AND SANITATION
0
Research Products
AFFORDABLE AND CLEAN ENERGY7
AFFORDABLE AND CLEAN ENERGY
0
Research Products
DECENT WORK AND ECONOMIC GROWTH8
DECENT WORK AND ECONOMIC GROWTH
0
Research Products
INDUSTRY, INNOVATION AND INFRASTRUCTURE9
INDUSTRY, INNOVATION AND INFRASTRUCTURE
0
Research Products
REDUCED INEQUALITIES10
REDUCED INEQUALITIES
0
Research Products
SUSTAINABLE CITIES AND COMMUNITIES11
SUSTAINABLE CITIES AND COMMUNITIES
0
Research Products
RESPONSIBLE CONSUMPTION AND PRODUCTION12
RESPONSIBLE CONSUMPTION AND PRODUCTION
0
Research Products
CLIMATE ACTION13
CLIMATE ACTION
0
Research Products
LIFE BELOW WATER14
LIFE BELOW WATER
0
Research Products
LIFE ON LAND15
LIFE ON LAND
0
Research Products
PEACE, JUSTICE AND STRONG INSTITUTIONS16
PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
PARTNERSHIPS FOR THE GOALS17
PARTNERSHIPS FOR THE GOALS
0
Research Products
Documents

86

Citations

1348

h-index

20

Go to Scopus profile
Documents

18

Citations

50

Go to WoS profile
Scholarly Output

4

Articles

3

Views / Downloads

17/16

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

10

Scopus Citation Count

10

Patents

0

Projects

0

WoS Citations per Publication

2.50

Scopus Citations per Publication

2.50

Open Access Source

3

Supervised Theses

0

JournalCount
Thoracic Research and Practice2
Human Vaccines & Immunotherapeutics1
Infectious Diseases and Clinical Microbiology1
Current Page: 1 / 1

Scopus Quartile Distribution

Competency Cloud

GCRIS Competency Cloud

Filters

2024 - 20254
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Letter
    Response to: Effectiveness of a Program to Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients with Chronic Respiratory Diseases: A Multicenter Cohort Study
    (Galenos Publ House, 2025-06-03) Şimşek, Nurdan; Altın, Sedat; Sayiner, Abdullah; Yalnız, Enver; Karakurt, Zuhal; Kul, Seval; Uslu, Ozgur; Veske, Nurdan Simsek; Karakut, Zuhal; Oruc, Ozlem
  • Thumbnail Image
    Article
    Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview With Data and Policy Insights From Turkiye
    (Doc Design Informatics Co Ltd, 2025-12-15) Durusu-Tanriover, Mine; Adak, Mine; Cicekcioglu, Hulya; Ozger, Hasan Selcuk; Zeren-Ozturk, Guzin; Sonmezer, Meliha Cagla; Sayiner, Abdullah; Adaş, Mine
    Streptococcus pneumoniae (pneumococcus) is responsible for various non-invasive and invasive infections and remains a major source of morbidity and mortality, particularly among older adults and at-risk adults. Vaccination is an effective way to prevent pneumococcal disease, and pneumococcal vaccines have been part of national immunization programs for many years. While vaccination coverage is high in children, uptake among older adults and at-risk adult populations remains below desired levels. This article aimed to highlight the burden of pneumococcal disease in adults, review current pneumococcal vaccines, and present a comprehensive overview supported by data from Turkiye.
  • Thumbnail Image
    Article
    Citation - WoS: 7
    Citation - Scopus: 7
    Effectiveness of a Program To Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients With Chronic Respiratory Diseases: a Multicenter Cohort Study
    (AVES, 2024-08-27) Karakurt, Z.; Yalnız, E.; Altın, S.; Oruç, Ö.; Uslu, Ö.; Veske, N.Ş.; Kılınç, O.; Sayıner, Abdullah; Kul, Seval; Şimşek, Nurdan
    OBJECTIVE: There is a need to increase patient and clinician awareness on the effectiveness of pneumococcal vaccination in at-risk groups. The aim of the study was to evaluate the effect of reminders for physicians and patients using the vaccination tracking system created in the hospital information management system (HIMS) on the vaccination rate, and the effect of pneumococcal vaccination on pneumonia-related hospitalization and mortality over a 12-month period. MATERIAL AND METHODS: This prospective observational cohort study was undertaken during a 2-year period in 3 tertiary care cen-ters. Patients were followed up for 12 months following vaccination, and hospital admissions and mortality were recorded via HIMS. During the campaign, HIMS transmitted pneumococcal immunization reminder messages in accordance with guideline recommendations to physicians’ computers and patients’ mobile phones. Educational posters on pneumococcal vaccination were posted in outpatient clinics. Regular seminars on the evidence for pneumococcal vaccination were organized. All patients who were hospitalized during the follow-up period for chronic obstructive pulmonary disease (COPD), asthma, lung cancer, or pneumonia were analyzed in relation to their vaccination history regarding clinical outcomes. RESULTS: A total of 29 530 patients were included in the study. During the study period, the annual vaccination rate increased by 74.4% and reached 4.8% in 3 hospitals (P = .001). The rates were 3.9% in patients older than 65 years without comorbidities and 5.2% in those with COPD and asthma (P = .002). In pneumococcal vaccine recipients, pneumonia-related hospital mortality was lower (relative risk (RR) = 0.19, CI 0.09-0.35, P < .001). CONCLUSION: It is possible to raise the rate of pneumococcal vaccination through awareness campaigns. Individuals with COPD and asthma are more willing to receive pneumococcal vaccination. Among patients hospitalized for pneumonia, prior pneumococcal vaccination is associated with lower mortality. © Author(s).
  • Thumbnail Image
    Article
    Citation - WoS: 3
    Citation - Scopus: 3
    Respiratory Syncytial Virus (RSV) Infections in Adults: Current Trends and Recommendations for Prevention - a Global Challenge From a Local Perspective
    (Taylor & Francis inc, 2025-06-18) Tanriover, Mine Durusu; Azap, Alpay; Cakir Edis, Ebru; Ozger, Hasan Selcuk; Pullukcu, Husnu; Sonmezer, Meliha Cagla; Sayiner, Abdullah
    Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTI) and a major health threat especially for children and older adults. Epidemiological data reveal that RSV-associated global mortality rates in individuals aged >= 70 years exceeded those in children aged < 5 years in 2019. Although effective interventions have decreased RSV-related deaths in children aged < 5 years over time, RSV appears increasingly significant issue for the elderly and adults with underlying health conditions. Furthermore, there is currently no specific treatment for RSV infections in adults, highlighting the importance of prevention. Recently, three vaccines (RSVPreF3, RSVpreF, and mRNA-1345) have been approved for adults to date. In this article, we aimed to review the characteristics of RSV infections in adults and the evidence on the safety and efficacy of RSV vaccines, with a glimpse of the current situation in T & uuml;rkiye- one of the low- and middle- income countries (LMICs).